Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.4670
+0.0012 (0.26%)
Aug 12, 2026, 11:55 AM EDT - Market open
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $42.91 million as of August 12, 2026. Its market cap has decreased by -29.37% in one year.
Market Cap
42.91M
Enterprise Value
162.20K
1-Year Change
-29.37%
Ranking
Category
Stock Price
$0.47
ChartMarket Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has decreased from $51.03M to $42.91M, a decrease of -15.91%. That is a compound annual growth rate of -3.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 42.91M | -68.23% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 46.36M |
| Seres Therapeutics | 46.13M |
| Metagenomi Therapeutics | 45.55M |
| Aligos Therapeutics | 45.46M |
| Veru Inc. | 44.78M |
| Grace Therapeutics | 44.60M |
| CervoMed | 41.80M |
| Serina Therapeutics | 41.69M |